Balanced news tone
News Sentiment
IPN sentiment intelligence
Ipsen S.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-4.8% over one week, +2.9% over four weeks, trend active, and materially above fair value.
Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Ipsen (ENXTPA:IPN) Stock Looks Like A Bargain On Cash Flow But Full On Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 07:00
- Source
- Market source
Ipsen (ENXTPA:IPN) Adds A Buy Back, Is The Stock Fully Priced?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 14:01
- Source
- simplywall.st
Ipsen SA Actuals & Estimates (EURONEXT:IPN)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 16:32
- Source
- TradingView
Ipsen (ENXTPA:IPN) Valuation Check After A Strong Year-To-Date Rise And Recent Share Price Pullback
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Market source
Ipsen announces the launch of an Employee Shareholding Plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Market source
Ipsen stock falls as Galderma feud clouds strong corabotase data
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Investing.com
Ipsen (ENXTPA:IPN) Valuation Check After Strong Recent Share Price Performance
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Is It Time To Reassess Ipsen (ENXTPA:IPN) After Its 65% One-Year Share Price Jump
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Apr 2026 07:00
- Source
- Market source
Ipsen’s IPN10200 Demonstrates Long-Lasting Efficacy in Phase II LANTIC Trial for Glabellar Lines
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Sep 2025 07:00
- Source
- Applied Clinical Trials Online
Ipsen Earnings: Dysport & Cabometyx Drive Growth as Pipeline Develops; Shares Slightly Undervalued
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Oct 2023 07:00
- Source
- Morningstar